Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.
about
Batch recall of French plasma-derived products due to variant Creutzfeldt-Jakob disease risk: the psychological impact on haemophilic patients, changes in their therapeutic demands and behaviour and ethical considerations.Treatment-related knowledge and skills of patients with haemophilia and their informal caregivers.The effect of peer support groups on self-care for haemophilic patients with HIV in Japan.
P2860
Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evaluation of the impact of in ...... ed or recombinant medications.
@en
Evaluation of the impact of in ...... ed or recombinant medications.
@nl
type
label
Evaluation of the impact of in ...... ed or recombinant medications.
@en
Evaluation of the impact of in ...... ed or recombinant medications.
@nl
prefLabel
Evaluation of the impact of in ...... ed or recombinant medications.
@en
Evaluation of the impact of in ...... ed or recombinant medications.
@nl
P2093
P1433
P1476
Evaluation of the impact of in ...... ved or recombinant medications
@en
P2093
Goudemand J
Magli-Barioz D
Ounnoughène N
P304
P356
10.1111/J.1365-2516.2004.00930.X
P50
P577
2004-09-01T00:00:00Z